Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patricia Munoz-Garrido

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
World Journal of Gastroenterology|January 18, 2013
Somatic second-hit mutations leads to polycystic liver diseasesJesús M Banales, Patricia Munoz-Garrido, Luis Bujanda
Hepatology (Baltimore, Md.)|April 19, 2020
Molecular Targets in CholangiocarcinomaColm J O'Rourke, Patricia Munoz-Garrido, Jesper B Andersen
Biochimica Et Biophysica Acta. Molecular Basis of Disease|June 25, 2017
Epigenome dysregulation in cholangiocarcinomaColm J O'Rourke, Patricia Munoz-Garrido, Esmeralda L Aguayo, et al.
Current Drug Targets|April 28, 2015
New Advances in the Molecular Mechanisms Driving Biliary Fibrosis and Emerging Molecular TargetsAlvaro Santos-Laso, Patricia Munoz-Garrido, Maialen Felipe-Agirre, et al.
Hepatology (Baltimore, Md.)|March 19, 2016
Soluble Adenylyl Cyclase Regulates Bile Salt-Induced Apoptosis in Human CholangiocytesJung-Chin Chang, Simei Go, Dirk R de Waart, et al.
World Journal of Gastroenterology|November 28, 2012
MicroRNAs in biliary diseasesPatricia Munoz-Garrido, Maite García-Fernández de Barrena, Elizabeth Hijona, et al.
The Journal of Biological Chemistry|November 8, 2014
Post-translational regulation of the type III inositol 1,4,5-trisphosphate receptor by miRNA-506Meenakshisundaram Ananthanarayanan, Jesus M Banales, Mateus T Guerra, et al.
Gut|January 18, 2014
Inhibition of metalloprotease hyperactivity in cystic cholangiocytes halts the development of polycystic liver diseasesAura D Urribarri, Patricia Munoz-Garrido, María J Perugorria, et al.
Hepatology (Baltimore, Md.)|April 12, 2019
Causes of hOCT1-Dependent Cholangiocarcinoma Resistance to Sorafenib and Sensitization by Tumor-Selective Gene TherapyElisa Lozano, Rocio I R Macias, Maria J Monte, et al.
Journal of Hepatology|February 27, 2023
MicroRNA-27a-3p targets FoxO signalling to induce tumour-like phenotypes in bile duct cellsLea Duwe, Patricia Munoz-Garrido, Monika Lewinska, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
World Journal of Gastroenterology|January 18, 2013
Somatic second-hit mutations leads to polycystic liver diseasesJesús M Banales, Patricia Munoz-Garrido, Luis Bujanda
Hepatology (Baltimore, Md.)|April 19, 2020
Molecular Targets in CholangiocarcinomaColm J O'Rourke, Patricia Munoz-Garrido, Jesper B Andersen
Biochimica Et Biophysica Acta. Molecular Basis of Disease|June 25, 2017
Epigenome dysregulation in cholangiocarcinomaColm J O'Rourke, Patricia Munoz-Garrido, Esmeralda L Aguayo, et al.
Current Drug Targets|April 28, 2015
New Advances in the Molecular Mechanisms Driving Biliary Fibrosis and Emerging Molecular TargetsAlvaro Santos-Laso, Patricia Munoz-Garrido, Maialen Felipe-Agirre, et al.
Hepatology (Baltimore, Md.)|March 19, 2016
Soluble Adenylyl Cyclase Regulates Bile Salt-Induced Apoptosis in Human CholangiocytesJung-Chin Chang, Simei Go, Dirk R de Waart, et al.
World Journal of Gastroenterology|November 28, 2012
MicroRNAs in biliary diseasesPatricia Munoz-Garrido, Maite García-Fernández de Barrena, Elizabeth Hijona, et al.
The Journal of Biological Chemistry|November 8, 2014
Post-translational regulation of the type III inositol 1,4,5-trisphosphate receptor by miRNA-506Meenakshisundaram Ananthanarayanan, Jesus M Banales, Mateus T Guerra, et al.
Gut|January 18, 2014
Inhibition of metalloprotease hyperactivity in cystic cholangiocytes halts the development of polycystic liver diseasesAura D Urribarri, Patricia Munoz-Garrido, María J Perugorria, et al.
Hepatology (Baltimore, Md.)|April 12, 2019
Causes of hOCT1-Dependent Cholangiocarcinoma Resistance to Sorafenib and Sensitization by Tumor-Selective Gene TherapyElisa Lozano, Rocio I R Macias, Maria J Monte, et al.
Journal of Hepatology|February 27, 2023
MicroRNA-27a-3p targets FoxO signalling to induce tumour-like phenotypes in bile duct cellsLea Duwe, Patricia Munoz-Garrido, Monika Lewinska, et al.
Pageof 2